AU6101200A - Novel cdnas associated with renal disease - Google Patents

Novel cdnas associated with renal disease

Info

Publication number
AU6101200A
AU6101200A AU61012/00A AU6101200A AU6101200A AU 6101200 A AU6101200 A AU 6101200A AU 61012/00 A AU61012/00 A AU 61012/00A AU 6101200 A AU6101200 A AU 6101200A AU 6101200 A AU6101200 A AU 6101200A
Authority
AU
Australia
Prior art keywords
renal disease
novel cdnas
cdnas associated
novel
renal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU61012/00A
Inventor
William E. Munger
Hong-Wei Sun
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ore Pharmaceuticals Inc
Original Assignee
Ore Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ore Pharmaceuticals Inc filed Critical Ore Pharmaceuticals Inc
Publication of AU6101200A publication Critical patent/AU6101200A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
AU61012/00A 1999-07-16 2000-07-17 Novel cdnas associated with renal disease Abandoned AU6101200A (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US14406999P 1999-07-16 1999-07-16
US60144069 1999-07-16
US14862699P 1999-08-12 1999-08-12
US60148626 1999-08-12
US16432899P 1999-11-09 1999-11-09
US60164328 1999-11-09
PCT/US2000/019304 WO2001005803A1 (en) 1999-07-16 2000-07-17 NOVEL cDNAs ASSOCIATED WITH RENAL DISEASE

Publications (1)

Publication Number Publication Date
AU6101200A true AU6101200A (en) 2001-02-05

Family

ID=27386028

Family Applications (1)

Application Number Title Priority Date Filing Date
AU61012/00A Abandoned AU6101200A (en) 1999-07-16 2000-07-17 Novel cdnas associated with renal disease

Country Status (2)

Country Link
AU (1) AU6101200A (en)
WO (1) WO2001005803A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1473801A (en) * 1999-11-12 2001-06-06 Human Genome Sciences, Inc. 6 human secreted proteins
JP2003238592A (en) * 2001-12-13 2003-08-27 Japan Tobacco Inc Medicine for regenerating tissue and blood vessel, and method therefor

Also Published As

Publication number Publication date
WO2001005803A1 (en) 2001-01-25
WO2001005803A9 (en) 2002-05-02

Similar Documents

Publication Publication Date Title
AU5723600A (en) Digital disease management system
AU4065800A (en) Intraluminal lining
AU1290001A (en) Antibodies
AU1173201A (en) Skin-gripper
AU3092999A (en) Digital-timeshare-exchange
AU2742100A (en) Light-reflecting molded
AU4935000A (en) Antibodies
AU2678800A (en) Modified calycins
AU5967600A (en) Candystraw
AU7514700A (en) Cyanopiperidines
AU4115400A (en) Short-circuiter
AU6440900A (en) Homogentisate-dioxygenase
AU2699800A (en) Organoceramics
AU6098300A (en) Follistatin-3
AU1466900A (en) Disease resistance factors
AU4561600A (en) Benzofuranylaminoalcohols
AU6101200A (en) Novel cdnas associated with renal disease
AU5765100A (en) Novel cdna associated with renal disease
AU2582200A (en) Windturbine
AU4435300A (en) Hula-hoop
AU1915601A (en) Periotome
AU4692800A (en) Disease resistance factors
AU2197301A (en) Microlamp
AU1737601A (en) Collectalbum
AU5487300A (en) Benzylpiperazinyl-indolinylethanones

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase